Menu
GeneBe

PAX4

paired box 4, the group of Paired boxes|PRD class homeoboxes and pseudogenes

Basic information

Region (hg38): 7:127610291-127618142

Links

ENSG00000106331NCBI:5078OMIM:167413HGNC:8618Uniprot:O43316AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • diabetes mellitus, noninsulin-dependent (Limited), mode of inheritance: Unknown
  • maturity-onset diabetes of the young (Supportive), mode of inheritance: AD
  • maturity-onset diabetes of the young type 9 (Limited), mode of inheritance: Unknown
  • monogenic diabetes (Refuted Evidence), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diabetes mellitusADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingEndocrine14602731; 15509590; 17130187; 16520476; 17426099; 18292467; 21263211

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PAX4 gene.

  • not provided (97 variants)
  • Maturity onset diabetes mellitus in young (49 variants)
  • not specified (24 variants)
  • Monogenic diabetes (7 variants)
  • Inborn genetic diseases (7 variants)
  • Type 2 diabetes mellitus;Diabetes mellitus, ketosis-prone;Maturity-onset diabetes of the young type 9 (7 variants)
  • Maturity-onset diabetes of the young type 9;Type 2 diabetes mellitus (5 variants)
  • Maturity-onset diabetes of the young type 9;Type 2 diabetes mellitus;Diabetes mellitus, ketosis-prone (5 variants)
  • Diabetes mellitus, ketosis-prone;Maturity-onset diabetes of the young type 9;Type 2 diabetes mellitus (5 variants)
  • Type 2 diabetes mellitus (3 variants)
  • PAX4-related condition (3 variants)
  • Maturity-onset diabetes of the young type 9 (2 variants)
  • Diabetes mellitus, ketosis-prone, susceptibility to (2 variants)
  • Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 9;Diabetes mellitus, ketosis-prone (1 variants)
  • Hyperglycemia (1 variants)
  • Type 2 diabetes mellitus;Maturity-onset diabetes of the young type 9 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PAX4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
11
clinvar
11
missense
43
clinvar
9
clinvar
52
nonsense
2
clinvar
2
start loss
0
frameshift
3
clinvar
3
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
4
non coding
14
clinvar
26
clinvar
15
clinvar
55
Total 0 0 64 46 15

Variants in PAX4

This is a list of pathogenic ClinVar variants found in the PAX4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-127610342-A-G Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358773
7-127610393-CAT-C Maturity onset diabetes mellitus in young Likely benign (Jun 14, 2016)358774
7-127610543-G-A Maturity onset diabetes mellitus in young Benign (Jun 14, 2016)358778
7-127610543-GTCAGTGT-ATCA Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358777
7-127610543-GTCA-ATCAGTGT Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358775
7-127610546-AGT-A Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358780
7-127610546-A-AGT Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358776
7-127610546-A-AGTGT Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358779
7-127610566-TGTGTGC-T Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358781
7-127610570-T-TGC Maturity onset diabetes mellitus in young Likely benign (Jun 14, 2016)358782
7-127610570-T-TGTGC Maturity onset diabetes mellitus in young Likely benign (Jun 14, 2016)358783
7-127610572-C-T Maturity onset diabetes mellitus in young Likely benign (Jun 14, 2016)358784
7-127610587-G-A Maturity onset diabetes mellitus in young Benign (Jun 14, 2016)358787
7-127610586-C-CACAT Maturity onset diabetes mellitus in young Benign (Jun 14, 2016)358785
7-127610586-C-CGCAT Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358786
7-127610587-G-GCATA Maturity onset diabetes mellitus in young Benign (Jun 14, 2016)358788
7-127610662-A-G Maturity onset diabetes mellitus in young Likely benign (Jun 14, 2016)358789
7-127610777-G-A Maturity onset diabetes mellitus in young Likely benign (Jun 14, 2016)358790
7-127610853-T-C Maturity onset diabetes mellitus in young • Type 2 diabetes mellitus • PAX4-related disorder Benign (Sep 05, 2021)358791
7-127610868-G-A not specified Uncertain significance (Jul 12, 2023)2577352
7-127610872-G-A PAX4-related disorder Likely benign (Aug 26, 2022)3047875
7-127610874-G-A Maturity onset diabetes mellitus in young • not specified • PAX4-related disorder Benign/Likely benign (Jun 26, 2019)358792
7-127610899-G-A PAX4-related disorder Likely benign (Mar 09, 2021)3031172
7-127610998-G-A Maturity onset diabetes mellitus in young Uncertain significance (Jun 14, 2016)358793
7-127611031-T-G Maturity onset diabetes mellitus in young Likely benign (Aug 09, 2018)358794

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PAX4protein_codingprotein_codingENST00000341640 95637
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0004230.9651257350131257480.0000517
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5602111891.110.00001202128
Missense in Polyphen9481.2511.1569858
Synonymous-0.6518072.91.100.00000362764
Loss of Function1.88816.10.4958.44e-7173

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001090.000105
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in the differentiation and development of pancreatic islet beta cells. Transcriptional repressor that binds to a common element in the glucagon, insulin and somatostatin promoters. Competes with PAX6 for this same promoter binding site. Isoform 2 appears to be a dominant negative form antagonizing PAX4 transcriptional activity.;
Disease
DISEASE: Diabetes mellitus, non-insulin-dependent (NIDDM) [MIM:125853]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:11723072}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, insulin-dependent (IDDM) [MIM:222100]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:15834548}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Diabetes mellitus, ketosis-prone (KPD) [MIM:612227]: An atypical form of diabetes mellitus characterized by an acute initial presentation with severe hyperglycemia and ketosis, as seen in classic type 1 diabetes, but after initiation of insulin therapy, prolonged remission is often possible with cessation of insulin therapy and maintenance of appropriate metabolic control. Metabolic studies show a markedly blunted insulin secretory response to glucose, partially reversible with the improvement of blood glucose control. Variable levels of insulin resistance are observed, especially in obese patients. Pancreatic beta-cell autoimmunity is a rare finding. {ECO:0000269|PubMed:15509590}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Maturity-onset diabetes of the young 9 (MODY9) [MIM:612225]: A form of diabetes that is characterized by an autosomal dominant mode of inheritance, onset in childhood or early adulthood (usually before 25 years of age), a primary defect in insulin secretion and frequent insulin-independence at the beginning of the disease. {ECO:0000269|PubMed:17426099}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Maturity onset diabetes of the young - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.215

Intolerance Scores

loftool
0.174
rvis_EVS
0.49
rvis_percentile_EVS
79.46

Haploinsufficiency Scores

pHI
0.0673
hipred
N
hipred_score
0.212
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.421

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pax4
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;

Zebrafish Information Network

Gene name
pax4
Affected structure
pancreatic A cell
Phenotype tag
abnormal
Phenotype quality
increased amount

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;circadian rhythm;animal organ morphogenesis;cell differentiation;endocrine pancreas development;response to drug;negative regulation of apoptotic process;positive regulation of cell differentiation;response to cAMP;retina development in camera-type eye
Cellular component
nucleoplasm
Molecular function
RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding